The global Spinal Muscular Atrophy (SMA) market is estimated to be valued at US$1,600.6 million in 2022 and is expected to exhibit a CAGR of 13.3% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:Spinal Muscular Atrophy is a rare genetic disorder characterized by the loss of motor neurons in the spinal cord and...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian